Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin vs Metformin for Preterm Preeclampsia Prevention
NCT05580523Unknown
- Sponsor
- The Chinese University of Hong Kong
- Start
- Jul 2023
- Primary completion
- Jan 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, double-blind trial of liquid metformin (Aspargo Labs) and aspirin in preeclampsia (3 arms), sponsored by The Chinese University of Hong Kong. Primary endpoint: Incidence of preterm preeclampsia (<37 weeks). Status: unknown.
02
Drugs
liquid metformin (Aspargo Labs)aspirin
03
Conditions
preeclampsia
Beyond the preview
Go deeper on NCT05580523.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05580523.